Tetratetrahydropalmatine-imperatorin solid self-emulsifying pharmaceutical composition and preparation method thereof

The solid self-emulsified pharmaceutical composition of yogusol-Oprienol is prepared by hot melt extrusion technology, and the oil phase is used to improve the compatibility and regulate the release behavior of traditional Chinese medicine and polymers, solving the problem of low bioavailability of traditional Chinese medicine ingredients. It achieves efficient analgesic efficacy and dosage flexibility.

CN118976024AActive Publication Date: 2024-11-19CHINA PHARM UNIV
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410765113.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-14
Publication Date
2024-11-19
Estimated Expiration
2044-06-14

AI Technical Summary

Technical Problem

Effective ingredients of traditional Chinese medicine such as yrovasoline and oleoprosapoxen lead to low oral bioavailability due to their hydrophobicity and low permeability. The existing improvement methods such as nanoparticle technology and solid solution systems have problems such as high production costs and poor stability, which are difficult to simultaneously Improve the physical and chemical properties of multiple Chinese medicine ingredients.

Method used

The solid self-emulsified pharmaceutical composition of yogusol-Ophimurin was prepared by hot melt extrusion technology. By dissolving the Chinese medicine ingredients in the oil phase and mixing them with the amphiphilic polymer, an amorphous solid dispersion was formed, and the oil phase was improved. Compatibility between traditional Chinese medicine and polymers and regulates drug release behavior.

Benefits of technology

It improves the dissolution and bioavailability of traditional Chinese medicine, simplifies the preparation process, realizes continuous production, conforms to the concept of green environmental protection, and provides better analgesic efficacy and dosage flexibility.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118976024A_ABST
    Figure CN118976024A_ABST
Patent Text Reader

Abstract

The invention discloses a tetrahydropalmatine-imperatorin solid self-emulsifying pharmaceutical composition and a preparation method of the tetrahydropalmatine-imperatorin solid self-emulsifying pharmaceutical composition. The tetrahydropalmatine-imperatorin solid self-emulsifying pharmaceutical composition is prepared from tetrahydropalmatine, imperatorin, an oil phase and an amphiphilic polymer. According to the traditional Chinese medicine amorphous solid dispersion and the preparation method thereof, the limitation of compatibility between traditional Chinese medicine components and a polymer matrix is improved by introducing an oil phase, and the traditional Chinese medicine amorphous solid dispersion is successfully prepared through a hot melt extrusion technology; on the other hand, a self-emulsifying drug release system formed in the dissolution process can promote intestinal permeation and absorption of the traditional Chinese medicine components, and the oral bioavailability of the low-solubility and / or low-permeability traditional Chinese medicine components is improved from two aspects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of traditional Chinese medicine preparations, and particularly relates to a tetrahydropalmatine-imperatorin solid self-emulsifying pharmaceutical composition and a preparation method thereof. Background Art

[0002] Traditional Chinese medicine has unique advantages in the field of disease prevention and treatment. However, many effective ingredients of traditional Chinese medicine with pharmacological activity have extremely low oral bioavailability due to their hydrophobicity and low permeability, which limits their clinical application. At present, methods for improving the solubility of poorly soluble drugs include amorphous solid dispersion technology, nanoparticle technology, solid solution system, ion pair strategy, use of surfactants, etc., but these methods all have defects, such as high production cost and nanotoxicity of nanoparticle technology, complex preparation process and poor stability of solid solution system, cumbersome salt formation process of ion pair strategy, and the use of surfactants may bring some toxic side effects, etc. In addition, the above-mentioned solubilization strategies are often difficult to improve the physical and chemical properties of multiple effective ingredients of traditional Chinese medicine at the same time.

[0003] Amorphous solid dispersion (ASD) technology is now widely used to improve poorly soluble drugs, to enhance drug dissolution and improve drug bioavailability. Amorphous drugs have higher surface free energy and apparent solubility than crystalline drugs. At the same time, the dispersing effect of solid carriers on drugs can increase the dissolution surface area of ​​drugs, improve the dissolution rate of poorly soluble drugs, and further improve their oral bioavailability. At present, the main methods for preparing amorphous solid dispersions in industry are spray drying and hot melt extrusion (HME). Among them, hot melt extrusion has attracted much attention due to the advantages of no solvent addition in the preparation process, continuous production, and green environmental protection.

[0004] However, the preparation of amorphous solid dispersions by hot melt extrusion is limited in two aspects. First, the hot melt extrusion process involves high temperature operation, and some drugs lose their activity under high temperature conditions, leading to the problem of thermal instability of the drugs; second, the preparation of amorphous solid dispersions is affected by the compatibility of the API and the excipients. Especially for the effective ingredients of traditional Chinese medicine, their diversity and complexity make it difficult to directly prepare a single homogeneous amorphous solid dispersion with polymer excipients, or face the risk of crystal transformation during preparation and storage. Therefore, it is of great significance to develop a new formulation strategy with application prospects to expand the application of amorphous solid dispersion technology in the field of traditional Chinese medicine.

[0005] Self-emulsifying drug delivery system (SEDDS) is a lipid-based technology that has attracted widespread attention in recent years in improving the solubility and bioavailability of poorly soluble drugs. The main defects of traditional SEDDS are poor drug loading capacity and unstable formulations, while the stability of SEDDS can be effectively improved through solidification technology. Among the existing SEDDS solidification technologies, hot melt extrusion technology has attracted widespread attention due to its advantages such as solvent-free addition and continuous manufacturing.

[0006] Yuanhuzhitongfang is a traditional Chinese medicine analgesic preparation. It has the effects of pain relief without addiction, regulating qi and promoting blood circulation, and is an ideal medicine for chronic pain and long-term pain relief in elderly patients. Yuanhuzhitongfang is composed of two traditional Chinese medicines, vinegar corydalis and angelica dahurica, and the analgesic active substances are clear, namely corydalis butylene and imperatorin. However, corydalis butylene and imperatorin are both low-solubility drugs, resulting in extremely low bioavailability. For patients taking Yuanhuzhitong dripping pills, the single dosage is large (20 to 30 pills at a time, three times a day), and the patient's medication compliance is poor. In order to reduce the dosage and the number of administrations, it is necessary to improve the existing dosage form of Yuanhuzhitongfang to improve its bioavailability. Therefore, it is of great significance to use corydalis butylene and imperatorin in Yuanhuzhitongfang as model drugs to explore the preparation process of solid self-emulsifying drug release system of traditional Chinese medicine, which provides a new idea for the development of new traditional Chinese medicine preparation strategies with application prospects. Summary of the invention

[0007] One of the purposes of the present invention is to provide a tetrahydropalmatine-imperatorin solid self-emulsifying pharmaceutical composition, which is made of tetrahydropalmatine, imperatorin, an oil phase and an amphiphilic polymer;

[0008] The mass ratio of tetrahydropalmatine to imperatorin is 1:0.5 to 1:5, preferably 1:1;

[0009] The ratio of the total mass of tetrahydropalmatine and imperatorin to the mass of the oil phase is 1:1 to 1:4, preferably 1:3;

[0010] The ratio of the total mass of tetrahydropalmatine and imperatorin to the mass of the amphiphilic polymer is 1:9.

[0011] Furthermore, the oil phase is a small molecule oil (such as eugenol, trans-anisene, nerol, carvacrol, cinnamaldehyde, benzyl alcohol, propylene glycol, etc.) or a medium / long chain oil (such as corn oil, soybean oil, walnut oil, almond oil, camellia oil, etc.), preferably eugenol, trans-anisene, benzyl alcohol, and more preferably eugenol.

[0012] Furthermore, the amphiphilic polymer is copovidone, preferably copovidone VA64.

[0013] The second object of the present invention is to provide a method for preparing the above-mentioned corydalis butylene glycol-imperatorin solid self-emulsifying pharmaceutical composition, specifically: firstly corydalis butylene glycol and imperatorin are mixed and dissolved in an oil phase, then an amphiphilic polymer is added and mixed, and the mixture is extruded by hot melt extrusion technology to obtain the solid self-emulsifying pharmaceutical composition.

[0014] Furthermore, the temperature of the hot melt extrusion is 160-180° C., and the rotation speed is 30-50 rpm.

[0015] The inventors have found that the addition of an oil phase improves the compatibility between Chinese medicine components and polymers, and increases the possibility of preparing an amorphous solid dispersion. The physical mixture of tetrahydropalmatine and imperatorin is directly mixed with an amphiphilic polymer and then hot-melt extruded to obtain a physical mixture extrudate (PM extrudate). The PM extrudate is observed by a polarizing microscope, and it is found that there are still a large number of crystals, which proves that the obtained product is not a single homogeneous amorphous solid dispersion. The physical mixture of tetrahydropalmatine and imperatorin is first dissolved in an oil phase, and then hot-melt extruded after being fully mixed with an amphiphilic polymer. The obtained product is observed by a polarizing microscope, and there is no birefringence phenomenon. After being characterized by a differential scanning calorimeter (DSC), a single glass transition temperature exists, which proves that the addition method of dissolving the Chinese medicine components in the oil phase can improve the compatibility of the Chinese medicine components and the amphiphilic polymer, and increases the possibility of preparing an amorphous solid dispersion of Chinese medicine.

[0016] In addition, the inventors have found that the addition of an oil phase can promote the formation of SEDDS during the release of the drug, thereby achieving the purpose of regulating the release of the drug. Through the mediation of different types of oil phases, tetrahydropalmatine and imperatorin can show different dissolution behaviors, thereby better regulating the analgesic efficacy of Yuanhu analgesic prescription through a solid self-emulsifying drug release system. Eugenol (Eug), trans-anisene (TA), and benzylalcohol (BP) were used to mediate the preparation of amorphous solid dispersions, and the corresponding characterization was performed. The obtained solubility enhancement effect of tetrahydropalmatine and imperatorin was eugenol system (Eug-VA64 ASD)> trans-anisene system (TA-VA64 ASD)> benzylalcohol system (BP-VA64ASD).

[0017] Furthermore, the inventors also found in the study that the addition of different amounts of oil phase can also achieve the purpose of regulating drug release behavior. Within a certain range, with the increase in the amount of oil phase, the solubility of corydalis ethyl and imperatorin increased significantly. Amorphous solid dispersions were prepared using different amounts of eugenol (the mass ratios of traditional Chinese medicine components to eugenol were 1:2, 1:2.5, and 1:3, respectively), and the corresponding characterization was performed. The obtained effect on improving the solubility of corydalis ethyl and imperatorin was high eugenol dosage (1:3) system > medium eugenol dosage (1:2.5) system > low eugenol dosage (1:2) system.

[0018] The present invention improves the compatibility limitations between the Chinese medicine components and the polymer matrix by introducing an oil phase, so as to successfully prepare a Chinese medicine amorphous solid dispersion through the HME technology. On the one hand, the solubility advantage of the amorphous solid dispersion is utilized, and on the other hand, the SEDDS formed during the dissolution process can promote the intestinal osmotic absorption of the Chinese medicine components, thereby improving the oral bioavailability of low-solubility and / or low-permeability Chinese medicine components from two aspects.

[0019] Beneficial effects:

[0020] (1) The present invention realizes the preparation of the solid self-emulsifying drug release system of tetrahydropalmatine-imperatorin traditional Chinese medicine by hot melt extrusion technology. Compared with the traditional amorphous solid dispersion preparation strategy, the addition of oil phase increases the compatibility between the traditional Chinese medicine multi-components and the amphiphilic polymer, increases the possibility of preparing the amorphous solid dispersion, and is simple and efficient;

[0021] (2) The oil phase used in the present invention has the function of regulating the dissolution behavior of the raw material drug. Through the mediation of different types of oil phases, or the mediation of different amounts of the same type of oil phase, corydalis butylene glycol and imperatorin can show different dissolution and release behaviors, thereby better regulating the analgesic efficacy of the Yuanhu analgesic prescription through the solid self-emulsifying drug release system and increasing the different dosage settings for the applicable population.

[0022] (3) The addition of the oil phase effectively improved the oral bioavailability of corydalis butylene and imperatorin in rats. This was not only due to the significantly improved solubility, but also due to the fact that the addition of the oil phase promoted the formation of a self-emulsifying drug delivery system during the drug release process.

[0023] (4) The preparation method of hot melt extrusion process can realize continuous production without adding solvents in the process, which conforms to the concept of green environmental protection and has broad application prospects. It provides new methods and technologies for the development of new dosage forms of traditional Chinese medicine and the continuous and modern production of traditional Chinese medicine. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 This is a polarizing microscope image of the extrudate of the physical mixture of tetrahydropalmatine, imperatorin and VA64.

[0025] Figure 2 Polarized light microscope images of tetrahydropalmatine-imperatorin-VA64 extrudates with different oil phases.

[0026] Figure 3 DSC characterization diagram of amorphous solid dispersions of traditional Chinese medicine prepared in three different oil phase systems.

[0027] Figure 4 DSC characterization diagram of amorphous solid dispersions of traditional Chinese medicine prepared in three different oil phase dosage systems.

[0028] Figure 5 These are the supersaturated dissolution curves of amorphous solid dispersion samples of traditional Chinese medicine with different oil phase types.

[0029] Figure 6 These are the dissolution curves of amorphous solid dispersions of traditional Chinese medicine prepared using three different oil phase dosage systems.

[0030] Figure 7 This is the Raman spectrum analysis diagram of the amorphous solid dispersion of traditional Chinese medicine mediated by eugenol.

[0031] Figure 8 This is the Raman spectrum analysis diagram of the amorphous solid dispersion of traditional Chinese medicine mediated by trans-anisene.

[0032] Fig. 9 This is the Raman spectrum analysis diagram of the amorphous solid dispersion of traditional Chinese medicine mediated by benzyl alcohol.

[0033] Fig.10 This is the 4-hour osmotic absorption result of amorphous solid dispersion of traditional Chinese medicine in the jejunum.

[0034] Fig.11 This is the particle size distribution diagram of amorphous solid dispersion of traditional Chinese medicine mediated by different eugenol dosages.

[0035] Fig.12 This is a pharmacokinetic study diagram of Eug-VA64 ASD amorphous solid dispersion and PM extrudate extrudate. DETAILED DESCRIPTION

[0036] The inventors found in previous studies that the addition of oil phase increased the compatibility between corydalis and imperatorin and the amphiphilic polymer, thereby successfully preparing corydalis-imperatorin amorphous solid dispersion; in addition, the dissolution behavior of the amorphous solid dispersion of traditional Chinese medicine can be effectively regulated by different types or amounts of oil phase. At the same time, the amorphous solid dispersion was proven to produce self-emulsification during the dissolution process, effectively improving the intestinal permeability of traditional Chinese medicine. In vivo studies have shown that the new formulation strategy proposed in the present invention effectively improves the oral bioavailability of corydalis-imperatorin amorphous solid dispersion.

[0037] The preferred embodiments of the present invention will be described in detail below in conjunction with examples. It should be understood that the following examples are provided only for the purpose of illustration and are not intended to limit the scope of the present invention. Those skilled in the art may make various modifications and substitutions to the present invention without departing from the purpose and spirit of the present invention.

[0038] Unless otherwise specified, the experimental methods used in the following examples are conventional methods.

[0039] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.

[0040] Example 1

[0041] Effect of adding oil phase on the preparation of amorphous solid dispersion of traditional Chinese medicine

[0042] Take equal amounts of corydaline and imperatorin, pass through a 40-mesh sieve 5 times for thorough mixing, and obtain a physical mixture.

[0043] 1.5 g of the physical mixture of tetrahydropalmatine and imperatorin was weighed and mixed with 13.5 g of copovidone VA64 through a 40-mesh sieve for 5 times to obtain a total mixture. The total mixture was then hot-melt extruded through a hot melt extruder under the condition that the temperature of the second zone, the third zone, and the fourth zone were all 170° C. to obtain a tetrahydropalmatine-imperatorin-VA64 physical mixture extrudate, which was recorded as sample 1 (PM extrudate).

[0044] Weigh 1 g of a physical mixture of corydalis ethyl and imperatorin, dissolve it in 3 g of eugenol (Eug) in a water bath at 80°C, add it to 9 g of copovidone VA64 after complete dissolution, stir to fully mix, and then hot-melt extrude the total mixture through a hot-melt extruder under the condition that the temperature of the second, third and fourth zones are all 170°C to obtain a corydalis ethyl-imperatorin-eugenol-VA64 amorphous solid dispersion, recorded as sample 2 (Eug-VA64 ASD).

[0045] Example 2

[0046] Effects of different oils on the preparation and characterization of amorphous solid dispersions of traditional Chinese medicine

[0047] Take equal amounts of tetrahydropalmatine and imperatorin, pass through a 40-mesh sieve 5 times for thorough mixing. Weigh 1 g of the physical mixture of tetrahydropalmatine and imperatorin, fully dissolve in 3 g of trans-anisene (TA) and benzyl alcohol (BP) respectively under 80°C water bath conditions, add to 9 g of copolyvidone VA64 respectively after complete dissolution, and stir to fully mix. Then, the total mixture is hot-melt extruded through a hot-melt extruder under the condition that the temperature of the second, third and fourth zones is 170°C to obtain tetrahydropalmatine-imperatorin-oil phase-VA64 amorphous solid dispersion, which are recorded as sample 3 (TA-VA64 ASD) and sample 4 (BP-VA64ASD), respectively.

[0048] Example 3

[0049] Effects of different oil phase dosages on the preparation and characterization of amorphous solid dispersions of traditional Chinese medicine

[0050] Take equal amounts of tetrahydropalmatine and imperatorin, pass through a 40-mesh sieve 5 times to mix thoroughly. Weigh 1g of the physical mixture of tetrahydropalmatine and imperatorin, fully dissolve it in 2g or 2.5g of eugenol in a water bath at 80°C, add it to 9g of copovidone VA64 after it is completely dissolved, and stir to mix it thoroughly. Then, the total mixture is hot-melt extruded through a hot-melt extruder at a temperature of 170°C in the second, third, and fourth zones to obtain tetrahydropalmatine-imperatorin-oil phase-VA64 amorphous solid dispersion, which are recorded as sample 5 (Eug-VA64 ASD (1:2)) and sample 6 (Eug-VA64 ASD (1:2.5)).

[0051] The samples in the above embodiment were tested as follows:

[0052] 1. Polarized light microscope

[0053] Instrument: Nikon Eclipse Ci-POL polarizing microscope (Nikon, Japan)

[0054] Light source: polarized light

[0055] Objective lens magnification: 5X

[0056] The polarizing microscope images of the above-mentioned tetrahydropalmatine-imperatorin solid dispersion samples 1-6 are as follows: Figure 1 and Figure 2As shown, the solid dispersion without adding oil phase (PM extrudate) has obvious birefringence, indicating that sample 1 is in crystalline form. After adding oil phase for mediation, no birefringence was observed in the prepared solid dispersions (samples 2-6) through polarizing microscope observation, indicating that there are no crystals in the samples and the samples are amorphous.

[0057] 2. Differential Scanning Calorimetry

[0058] Instrument: DSC 3500 Differential Scanning Calorimeter (Netzsch, Germany)

[0059] Sample plate type: solid plate

[0060] Temperature range: 20-200℃

[0061] Heating rate: 10℃ / min

[0062] The DSC detection spectrum of the tetrahydropalmatine-imperatorin solid dispersion sample 2-6 is as follows: Figure 3 (solid dispersions of different oil phase types), Figure 4 (Solid dispersions with different oil phase dosages) After the addition of the oil phase, the DSC detection spectra of the prepared solid dispersions all have a single glass transition temperature, indicating that the addition of the oil phase increases the compatibility between the API and the excipients, and the amorphous solid dispersion is successfully prepared.

[0063] 3. Supersaturated dissolution determination

[0064] Instrument: RC806ADK intelligent dissolution instrument (Tianjin Tianda Tianfa Technology Co., Ltd.)

[0065] Method: According to the second method (paddle method) of dissolution and release determination in the 2020 edition of the Chinese Pharmacopoeia, general chapter 0931, small cup method. Dissolution medium: 150 mL pure water

[0066] Temperature: 37±0.5℃

[0067] Speed: 100rpm

[0068] Test solution: Weigh 1.5 g of each of the solid dispersion samples 1-6 of tetrahydropalmatine and imperatorin and put them into the dissolution cup. After starting the test, take 2 mL of samples at 5, 10, 15, 30, 45, 60, 90, 120, 180, 240, 360, 480, 720, and 1440 min, and replenish the medium of the same volume and temperature in time. The taken out dissolution solution is filtered through a 0.45 μm PTFE aqueous phase filter membrane. Take the subsequent filtrate as the test solution. The concentrations of tetrahydropalmatine and imperatorin were determined by high performance liquid chromatography.

[0069] Reference solution: Imperatorin reference substance: Take an appropriate amount of imperatorin reference substance, weigh it accurately, and add methanol to prepare a solution containing 9.8 μg of imperatorin per 1 mL. Tetrahydropalmatine reference substance: Take an appropriate amount of Tetrahydropalmatine reference substance, weigh it accurately, and add methanol to prepare a solution containing 24.5 μg of Tetrahydropalmatine per 1 mL.

[0070] The determination of tetrahydropalmatine and imperatorin was carried out by high performance liquid chromatography, and the chromatographic column was C18, 4.6*250mm, 5μm; the mobile phase is acetonitrile-0.1% phosphoric acid aqueous solution (adjusted to pH 6.0 with triethylamine), the ratio of organic phase to aqueous phase is 65:35, the flow rate is 1mL / min, the column temperature is 40℃, the detection wavelength is 280nm, and the injection volume is 20μL. The above solution is placed in a high performance liquid chromatograph for peak area determination, thereby calculating its solubility.

[0071] The supersaturated dissolution curves of solid dispersions (samples 1-4) with different oil phase types are as follows: Figure 5 As shown in the figure, it can be seen that the three oils have different effects on the dissolution behavior of tetrahydropalmatine and imperatorin, with eugenol being the best, followed by trans-anisene, and benzyl alcohol being the worst. The supersaturated dissolution curves of the solid dispersions (samples 2, 5, and 6) with different amounts of the same oil phase are shown in the figure. Figure 6 As shown, it can be seen that with the increase of oil phase mass, the dissolution rate will also increase, and the platform dissolution will be improved. However, in order to ensure the drug loading amount, it is preferred that the ratio of traditional Chinese medicine to oil phase is 1:3 for the preparation of traditional Chinese medicine solid self-emulsifying drug release system.

[0072] 4. Effect of different oil phase types on the interaction of traditional Chinese medicine amorphous solid dispersion system

[0073] Laser confocal Raman spectroscopy was used to determine the effect of different oil phase types on the interaction force of amorphous solid dispersion systems. The samples tested were tetrahydropalmatine, imperatorin, VA64, eugenol (Eug), trans-anisene (TA), benzyl alcohol (BP), tetrahydropalmatine-imperatorin-oil phase-VA64 amorphous solid dispersion (Eug-VA64 ASD, TA-VA64 ASD, BP-VA64 ASD). The laser wave number used for detection was 780nm and the test range wave number was 400-4000cm -1 .

[0074] Test results such as Figure 7 , 8, as shown in Figure 9. It can be seen that in the amorphous solid dispersion system mediated by eugenol, there are four action sites that are significantly shifted; in the amorphous solid dispersion system mediated by trans-anisene, there are two action sites that are significantly shifted; in the amorphous solid dispersion mediated by benzyl alcohol, there is one action site that is significantly shifted. Therefore, in the three amorphous solid dispersion systems of traditional Chinese medicine, the magnitude relationship of the intermolecular interaction force may be eugenol system> trans-anisene system> benzyl alcohol system, which further verifies that in the supersaturated dissolution process, the dissolution behavior of the amorphous solid dispersion of traditional Chinese medicine in the eugenol system is the best, the system is the most stable, the trans-anisene system is second, and the benzyl alcohol system is the worst.

[0075] 5. Effect of the addition of oil phase on the permeation and absorption of amorphous solid dispersions of traditional Chinese medicine

[0076] Intestinal tissues of male Sprague-Dawley (SD) rats were used for permeation and absorption investigation. Since the intestinal tissue area of ​​SD rats is small, an intestinal eversion model was used for investigation, and microvilli and mucus layer were presented on the donor side to increase the receptor drug concentration, which is convenient for intestinal permeation measurement. A 5 cm segment of rat jejunum was taken, and the jejunum segment was washed three times with PBS 6.8 buffer using a blunt-end syringe. After intestinal eversion, one end of the intestine was ligated with silk thread, and 1 mL of Hank's balanced salt solution (HBSS) was injected into the intestine using a pipette, and then the intestinal sac at the other end was ligated with silk thread; the intestinal sac was placed in a dissolution cup containing 150 mL of pure water medium, and 1.5 g of sample 1 (PM extrudate) and sample 2 (Eug-VA64ASD) powder were added respectively. The dissolution cup containing the sample solution was used as the donor chamber, and the everted intestinal sac containing HBSS was used as the receptor chamber. The same dissolution conditions as the supersaturated dissolution assay were used. The intestinal sac was removed at 4 h, and the surface of the intestinal sac was rinsed three times with saline; the intestinal sac was cut open and the intestinal fluid was placed in a 2 mL centrifuge tube. After the slurry was centrifuged at 12000 rpm (TGL-16G, Shanghai Anting Scientific Instrument Factory) for 10 min, 100 μL of supernatant and 200 μL of acetonitrile were vortexed (Vortex-Genie2, American Scientific Industries) for 2 min to fully precipitate the protein, and then centrifuged at 12000 rpm for 10 min; the supernatant was taken as the test solution, and corydaline and imperatorin were analyzed by the above-mentioned high performance liquid chromatography detection method. Each sample was measured in parallel three times.

[0077] The 4h jejunal osmotic absorption of the obtained samples is as follows Fig.10As shown. Compared with the PM extrudate system, the addition of eugenol improved the permeation and absorption of tetrahydropalmatine (THP) and imperatorin (IMP), indicating that the addition of the oil phase improved the intestinal permeability of the two traditional Chinese medicine components to a certain extent.

[0078] 6. Effect of the addition of oil phase on the time-particle size curve of amorphous solid dispersion of traditional Chinese medicine during dissolution and release

[0079] Test solution: Weigh 1.5g of each powder of Corydalis butylene-imperatorin solid dispersion sample 1-2 and sample 5-6 respectively. The test was carried out using the RC806ADK intelligent dissolution instrument (Tianjin Tianda Tianfa Technology Co., Ltd.), according to the second method (paddle method) of the 2020 edition of the General Rules 0931 of the Chinese Pharmacopoeia, with 150mL of water as the dissolution medium, the test temperature was 37±0.5℃, and the speed was 100rpm. After the start of the test, 5mL of samples were taken at 10, 15, 30, 60, 120, 240, 360, 480, 720, and 1440min as the test solution, and the medium of the same volume and temperature was replenished in time. The particle size of the dissolved samples at each time was determined by a dynamic light scattering particle size analyzer.

[0080] The time-particle size curve of eugenol-mediated amorphous solid dispersion is shown in Fig.11 As shown. It can be seen that the addition of eugenol promotes the formation of SEDDS during the dissolution and release process of amorphous solid dispersions of traditional Chinese medicine. The amorphous solid dispersions formed by eugenol have small particle sizes and stable particle size distribution during the dissolution and release process. With the increase of the amount of eugenol, the particle size formed by the amorphous solid dispersions of traditional Chinese medicine during the dissolution and release process becomes smaller, the specific surface area of ​​the particles increases, the dissolution rate is faster, and the SEDDS system formed is more stable. However, in order to ensure the drug loading, the ratio of traditional Chinese medicine to eugenol is preferably 1:3 for the preparation of the solid self-emulsifying drug release system of traditional Chinese medicine. In addition, the particle size formed by sample 1 (PM extrudate) during the dissolution and release process is too large, and its effective particle size cannot be detected by the dynamic light scattering particle size analyzer. It shows that the addition of the oil phase promotes the formation of SEDDS during the dissolution and release process of traditional Chinese medicine, which can promote the penetration and absorption of traditional Chinese medicine to a certain extent.

[0081] 7. Effect of the addition of oil phase on the pharmacokinetic parameters of amorphous solid dispersions of traditional Chinese medicine

[0082] Oral pharmacokinetics of SD rats were investigated using Eug-VA64 ASD and PM extrudate samples. Rats were fasted for 12 hours in advance and weighed. Oral gavage was used for administration, and the dosage of tetrahydropalmatine and imperatorin was 30 mg / kg. 1 mL of blood was collected from the orbital venous plexus of rats at 30, 60, 90, 120, 180, 240, 360, 480, and 600 minutes after gavage. The following treatments were used for the detection of tetrahydropalmatine and imperatorin:

[0083] Tetrahydropalmatine: Take 150 μL of plasma sample, place it in a 2 mL centrifuge tube, add 20 μL of 45.2 μg / mL internal standard (tetrahydropalmatine) methanol solution, add 50 μL of 1 mol / L NaOH solution for alkalization, vortex oscillation for 5 min; add 1.5 mL of n-hexane:isopropanol (95:5) for extraction, vortex oscillation for 5 min, centrifuge at 12000 rpm for 10 min. Take the upper organic phase, blow dry in a nitrogen blower at 40°C, and add 150 μL of the corresponding mobile phase to the residue for re-dissolution.

[0084] Imperatorin: Take 150 μL of plasma sample and place it in a 2 mL centrifuge tube, add 20 μL of 29.2 μg / mL internal standard (isoimperatorin) methanol solution, vortex for 5 min, add 1.5 mL of ethyl acetate: petroleum ether (1:1) for extraction, vortex for 5 min, centrifuge at 12000 rpm for 10 min. Take the upper organic phase, blow dry in a nitrogen blower at 40 ° C, and add 150 μL of the corresponding mobile phase to the residue for re-dissolution.

[0085] The samples were tested by high performance liquid chromatography. C18, 4.6*250mm, 5μm; the mobile phase is acetonitrile-0.1% phosphoric acid aqueous solution (adjusted to pH 6.0 with triethylamine), the ratio of organic phase to aqueous phase is 60:40, the flow rate is 1mL / min, the column temperature is 40°C, the detection wavelength for tetrahydropalmatine sample is 280nm, the detection wavelength for imperatorin sample is 300nm, and the injection volume is 20μL. The above solution is placed in a high performance liquid chromatograph for peak area determination, thereby calculating its blood drug concentration.

[0086] The pharmacokinetic parameters of Eug-VA64 ASD and PM extrudate samples are shown in Table 1 .

[0087] Table 1 Pharmacokinetic parameters of Eug-VA64 ASD and PM extrudate in rats after oral administration

[0088]

[0089] It can be seen that for tetrahydropalmatine, the AUC of Eug-VA64 ASD 0-10h and C max Compared with PM extrudate samples, the AUC of Eug-VA64 ASD was 4.34 and 4.33 times higher than that of PM extrudate samples. 0-10h and C max Compared with PMextrudate samples, the concentrations of tetrahydropalmatine (THP) and imperatorin (IMP) increased by 3.74 and 4.49 times, respectively, indicating that the addition of eugenol significantly increased the drug absorption of tetrahydropalmatine (THP) and imperatorin (IMP) in rats. In addition, the blood concentration-time curves of tetrahydropalmatine and imperatorin are shown in Figure 2. Fig.12 As shown, it can be seen that the blood drug concentration of the amorphous solid dispersion (Eug-VA64 ASD) formed by eugenol is much higher than that of the PM extrudate sample within a specific period of time, indicating that the addition of eugenol effectively improves the oral bioavailability of corydalis and imperatorin.

Claims

1. A solid self-emulsifying pharmaceutical composition of tetrahydropalmatine and imperatorin, characterized in that: It is made of tetrahydropalmatine, imperatorin, oil phase and amphiphilic polymer; The mass ratio of tetrahydropalmatine to imperatorin is 1:0.5-1:5; The ratio of the total mass of tetrahydropalmatine and imperatorin to the mass of the oil phase is 1:1-1:4; The ratio of the total mass of tetrahydropalmatine and imperatorin to the mass of the amphiphilic polymer is 1:

9.

2. The corydaline-imperatorin solid self-emulsifying pharmaceutical composition according to claim 1, characterized in that: The oil phase is small molecule oil or medium / long chain oil.

3. The corydaline-imperatorin solid self-emulsifying pharmaceutical composition according to claim 2, characterized in that: The small molecule oil is eugenol, trans-anisene, nerol, carvacrol, cinnamaldehyde, benzyl alcohol or propylene glycol.

4. The corydaline-imperatorin solid self-emulsifying pharmaceutical composition according to claim 3, characterized in that: The small molecule oil is eugenol, trans-anisene or benzyl alcohol.

5. The corydaline-imperatorin solid self-emulsifying pharmaceutical composition according to claim 1, characterized in that: The amphiphilic polymer is copolyvidone.

6. The method for preparing the tetrahydropalmatine-imperatorin solid self-emulsifying pharmaceutical composition according to any one of claims 1 to 5, characterized in that: Tetrahydropalmatine and imperatorin are first mixed and dissolved in an oil phase, and then an amphiphilic polymer is added and mixed. The mixture is extruded by hot melt extrusion technology to obtain the solid self-emulsifying pharmaceutical composition.

7. The preparation method according to claim 6, characterized in that The temperature of the hot melt extrusion is 160-180° C., and the rotation speed is 30-50 rpm.

8. A pharmaceutical composition, characterized in that A solid self-emulsifying pharmaceutical composition comprising corydalis butylene glycol-imperatorin according to any one of claims 1 to 5.

Citation Information

Patent Citations

  • Formula of pain-relieving tetrahydropalmatine controlled release tablet and preparation technology thereof

    CN101637485A

  • New type slightly soluble oral medicine self-emulsification preparation and preparation method thereof

    CN101862306A

  • Medicinal composition containing tetrahydropalmatine and imperatorin

    CN102429905A

  • Self-emulsifying solid oral dosage forms of allergen and their preparation thereof

    US20210236628A1